Genome Engineering Editing Market Summary
Genome Engineering Editing is a modern molecular biology technology that involves targeted modifications to the genome of an organism to change the sequence of a target gene or regulate its expression. This technology is largely based on genome editing tools such as CRISPR-Cas9, which allows scientists to precisely add, delete or replace an organism's genes.
According to the new market research report “Global Genome Engineering Editing Market Report 2023-2029”, published by QYResearch, the global Genome Engineering Editing market size is projected to reach USD 23.13 billion by 2029, at a CAGR of 18.5% during the forecast period.
According to QYResearch Top Players Research Center, the global key manufacturers of Genome Engineering Editing include Thermo Fisher Scientific, AstraZeneca, SIGMA ALDRICH, Agilent Technologies, Illumina, Lonza, QIAGEN NV, Bio Rad, CRISPR Therapeutics, Dharmacon（Horizon Discovery）, etc.
In 2022, the global top five players had a share approximately 50.0% in terms of revenue.
In terms of product type, CRISPR RNP is the largest segment, hold a share of 38.7%,
In terms of product application, GMP is the largest application, hold a share of 69.8%,
Market Drivers:
Technological innovation: The emergence of new editing technologies and tools is driving the development of the entire industry. Over time, scientists continue to improve and develop new gene-editing methods, increasing editing efficiency, precision, and scope. For example, the introduction of technologies such as Prime Editing and Base Editing provides more possibilities for precise gene editing.
Wide range of applications: The application scope of genome engineering editing technology continues to expand, covering many fields such as medicine, agriculture, industry, and environment. This widespread use makes the technology more attractive, driving more investment and research.
Breakthroughs in medical applications: In the medical field, genome engineering editing is expected to be used to treat a range of genetic diseases. Successful therapeutic applications will accelerate the development of the industry, while also attracting more attention and investment.
Restraint:
Technical limitations: Although gene editing technology has made significant progress, there are still some technical limitations, such as editing efficiency, accuracy, selection of target genes, etc. The challenges of improving these aspects may require long-term research and technological innovation.
Side Effects and Safety Issues: When performing genome editing, there is a degree of uncertainty and risk, including possible side effects and unintended genetic modifications. Ensuring editorial security and control is an ongoing concern.
Cost Issues: The implementation and application of genome engineering edits can involve significant costs, including the costs of technology development, research, clinical trials, and commercialization. This could impact the accessibility and widespread adoption of the technology.
Opportunity:
Breakthroughs in the field of medical and health: Genome editing technology is expected to solve the genomic components of many genetic diseases and diseases, such as cancer, hereditary blindness, etc. By editing the genome, diseases can be treated more precisely, providing more possibilities for personalized medicine and customized drug treatments.
Agriculture and food security: Genome editing technology can be used to improve crops to increase yields, disease resistance and nutritional value to meet the challenges of global population growth and climate change. In addition, it can also be used to improve food quality and preservation capabilities and enhance food safety.
Biopharmaceuticals: Genome editing technology has broad application prospects in the field of biopharmaceuticals. It can be used to produce more effective and safer biopharmaceuticals, reduce production costs, and improve the stability and efficacy of drugs.
About The Authors
|
|
Ziyi Fan |
|
|
Lead Author |
||
|
Consumer Goods, Equipment & Parts, Packaging, etc. |
About QYResearch
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.
QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.